Webinar: Drug Establishment Licencing: An Industry Perspective
MARK YOUR CALENDARS for Wednesday, November 24th, 2021; 5:00 pm - 6:00 pm EST, and share this news with your colleagues!
Topic: Drug Establishment Licencing: An Industry Perspective
Description: Please join Brian for an overview of current DEL and importation process. Hear about remote inspections, experiences under the interim order and perspective on the post-interim order transition. DEL- related challenges and potential solutions to address product release and demonstration of foreign site compliance.
Registration Deadline: Monday, November 22, 2021
*Registrants may be substituted, but no refunds will be issued after the deadline.
*Disclaimer: CAPRA reserves the right to make amendments to the conference (including but not limited to speakers' identity, topics, locations, the timing of speakers) without notice to you. If the conference is cancelled for any reason whatsoever, such reason not within the control of CAPRA, CAPRA shall not be liable for any cost or loss otherwise incurred.
Event Registration Form: Please add your First name, Last name and the Email address that you will use to log in the day of the webinar.
Be sure to check system requirements to avoid any connection issues the day of the event.
In case of unexpected interruptions such as a power outage please log back, and the webinar will restart from where it was disconnected.
Speakers / Panelists
-
Brian Randall
Director, Quality Assurance, Innomar Strategies Inc.
Brian Randall
Director, Quality Assurance, Innomar Strategies Inc.
Innomar Strategies Inc.
In his present role as Director, QA at Innomar, Brian is the Head of Quality for numerous client drug establishment licenses (DELs), covering a full range of product types and management of more than 400 foreign sites. Brian started his career in research at McMaster Hospital in the development of ELISAs and subsequently moved to the diagnostic industry developing kits for detection of peanuts in food.Brian brings more than 25 years of experience to this role, including 10 years in Quality Assurance and 15 years in Quality Consulting. Brian’s previous companies include GlaxoSmithKline, CanReg, OptumInsight and Therapeutic Products Inc. (TPIreg). He is an innovative thinker who excels at Quality Systems development and compliance. Brian is well known to the Inspectorate and has hosted over 40 Health Canada inspections.
Registration is now closed